Vistagen Therapeutics, Inc. (NASDAQ:VTGN) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on February 12, 2026. The Healthcare company reported…
Vistagen Therapeutics, Inc. (NASDAQ:VTGN) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on February 12, 2026.
The Healthcare company reported Q0 revenue of .
Vistagen Therapeutics, Inc.'s stock currently trades at $0.55 with a market capitalization of $129.3M.
Current market data
NASDAQ · VTGN
$0.24
Down: -$0.01 · -4.59%
Live quote updated
Keep reading
sec_filing ·
earnings ·
price ·
earnings ·
